Clinical trial
BaSES Trial: Basel Starch Evaluation in Sepsis
NCT00273728 · University Hospital, Basel, Switzerland, Other · Completed
Key facts
| NCT number | NCT00273728 |
|---|---|
| Title | BaSES Trial: Basel Starch Evaluation in Sepsis |
| Official title | Basel Study for Evaluation of Starch (130;0.4) Infusion in Septic Patients: BaSES (130;0.4) Trial |
| Acronym | BaSES |
| Lead sponsor | University Hospital, Basel, Switzerland, Other |
| Collaborators | Fresenius AG Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Sepsis, Severe Sepsis, Septic Shock |
| Intervention type | Drug |
| Interventions | hydroxy-ethyl starch (MW 130, 0.4) vs. normal saline |
| Enrollment | 231 |
| Start date | May 1, 2005 |
| Primary completion | Jun 1, 2010 |
| Completion | May 1, 2011 |
| First posted | Jan 9, 2006 |
| Last update posted | Aug 12, 2011 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: